Cart
sales@molnova.com
Methylnitrosourea
CAS No. 684-93-5
Methylnitrosourea ( —— )
Catalog No. M19334 CAS No. 684-93-5
N-Nitroso-N-methylurea is a nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 61 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMethylnitrosourea
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Nitroso-N-methylurea is a nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.
-
DescriptionN-Nitroso-N-methylurea is a nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number684-93-5
-
Formula Weight103.08
-
Molecular FormulaC2H5N3O2
-
Purity98%
-
Solubility——
-
SMILESNC(=O)N(C)N=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yoshizawa K, et al. Caspase-3 inhibitor rescues N -methyl- N -nitrosourea-induced retinal degeneration in Sprague-Dawley rats. Exp Eye Res. 2000 Dec;71(6):629-35.
molnova catalog
related products
-
Dabcyl acid
Dabcyl acid is the original dark fluorescence quencher.
-
PSB-603
Adenosine A2B receptor antagonist.
-
Fosravuconazole L-ly...
FosravuconazoleL-lysine ethanolate is a broad-spectrum antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole.
